• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GYRUS ACMI, INC. SHOCKPULSE LITHOTRIPSY PROBE, REUSABLE,; LITHOTRIPTOR, ULTRASONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GYRUS ACMI, INC. SHOCKPULSE LITHOTRIPSY PROBE, REUSABLE,; LITHOTRIPTOR, ULTRASONIC Back to Search Results
Model Number SPL-PR376
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Urinary Tract Infection (2120)
Event Date 09/29/2022
Event Type  Injury  
Manufacturer Narrative
Since the literature described "shockpulse-se", olympus selected "spl-pr376" as a representative product.The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article doi: 10.1089/end.2022.36001.Abstracts provided for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled "comparison of swiss lithoclast® trilogy and shockpulse-se as energy source in percutaneous nephrolithotomy for staghorn stones: a matched pair analysis." this study aimed to evaluate efficacy of swiss lithoclast trilogy (boston scientific, usa) and shockpulse-se (olympus) in pcnl for staghorn stones in 85 patients.Trilogy had 81.48 % clearance and shockpulse-se had 61.53% clearance at 48 hours in first stage pcnl.18.51% patients of trilogy and 38.46% patients of shockpulse-se required subsequent staged pcnl.Trilogy had 92.59% stone free rate at 3-month follow-up while shockpulse-se had 80.76% stone free rate.As per the study results, trilogy has comparable stone fragmentation rate with shockpulse-se in managing staghorn renal stones.Complications and instrument malfunction were also comparable for trilogy and shockpulse-s.Type of adverse events/number of patients clavien-dindo grade-ii complications -3 (uti with fever) malfunctions suction block - 2 probe breaks - 3 this literature article requires 6 reports.The related patient identifiers are as follows: (b)(6) (for clavien-dindo grade-ii complications), (b)(6) (for suction block 1/2), (b)(6) (for suction block 2/2), (b)(6) (for probe break 1/3), (b)(6) (for probe break 2/3), (b)(6) (for probe break 3/3).This medwatch report is for patient identifier (b)(6).
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.This supplemental report includes a correction to e4 to provide information that was inadvertently not included on the initial medwatch.Also, new information added to d4 and d8.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHOCKPULSE LITHOTRIPSY PROBE, REUSABLE,
Type of Device
LITHOTRIPTOR, ULTRASONIC
Manufacturer (Section D)
GYRUS ACMI, INC.
9600 louisiana avenue north
brooklyn park MN 55445
Manufacturer (Section G)
GYRUS ACMI, INC.
9600 louisiana avenue north
brooklyn park MN 55445
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16132238
MDR Text Key307023754
Report Number3011050570-2023-00006
Device Sequence Number1
Product Code FEO
UDI-Device Identifier00821925043817
UDI-Public821925043817
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K142428
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSPL-PR376
Device Lot NumberUNKNOWN(LITERATURE)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/16/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-